Prior to joining Be Bio, Joanne was the chief operating officer and business unit head, oncology at bluebird bio, where she led the team who grew bluebird oncology from a single-candidate effort within a rare disease gene therapy company to a leading oncology cell therapy business. Previously, she held executive roles as chief business officer of bluebird bio, vice president of transactions at Merck, vice president of business development at Pfizer, and senior vice president at Gene Logic. Joanne worked in the healthcare practice at BCG, was a post-doctoral fellow in Bob Langer’s lab at the Harvard-MIT Division for Health Science and Technology, and holds a PhD in physics from the Catholic University of America.